click to enlarge
Lisa A. Carey, MD
Thursday, Sept. 20, 2012
We are pleased to announce the appointment of Lisa A. Carey, MD, a nationally-recognized clinical researcher and physician, as Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital, effective immediately.
Dr. Carey, a member of the UNC faculty for more than ten years, is Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, Professor of Medicine, Medical Director of the UNC Breast Center, and Associate Director for Clinical Research at UNC Lineberger Comprehensive Cancer Center.
“Dr. Carey is exactly the right leader for these key roles,” said William L. Roper, MD, MPH, Dean of the UNC School of Medicine and CEO of UNC Health Care. “This is an area of great importance to our health care system, and to the people of North Carolina.”
In her role as division chief, Dr. Carey will be responsible for the overall administration of the division, including clinical practice, educational activities, research programs, fiscal management, and meeting the missions of patient care, research, and education. This includes leading a diverse group of more than 50 clinicians, investigators, physician extenders and fellows, which has grown substantially.
“Dr. Carey is a truly outstanding physician, researcher, and teacher,” said Marschall Runge, MD, PhD, Executive Dean of the School of Medicine and Chair of the Department of Medicine, “and I am confident she will continue to excel as a leader.”
The interim Division Chief for the past year, Thomas C. Shea, MD, Professor of Medicine, Director of the Bone Marrow and Stem Cell Transplant Program, and Associate Director for Outreach at UNC Lineberger, will continue his leadership of the Cancer Center’s relationships across the state and a major expansion of Bone Marrow Transplantation services, including developing an outpatient unit. “We owe many thanks to Dr. Shea for his excellent work as interim chief of the division. We truly appreciate his service to the School of Medicine,” said Dr. Runge.
As Physician-in-Chief, Dr. Carey is responsible for the clinical operations of the N.C. Cancer Hospital and will work with Shelley Earp, MD, Director of UNC Lineberger and UNC Cancer Care to coordinate care of cancer patients throughout the UNC Health Care System. More than 135,000 patients with cancer are served each year by UNC Health Care through inpatient and outpatient clinics.
As Physician-in-Chief, Dr. Carey will report to Dr. Earp, in his role as Director of UNC Cancer Care, Brian Goldstein, MD, MBA, Chief Operations Officer of UNC Hospitals and Marlene Rifkin, Senior Vice President of UNC Hospitals who oversees Oncology Services. In her role as Division Chief she will report to Dr. Runge, Chair of the Department of Medicine.
“Dr. Carey is recognized internationally as one of the world’s most thoughtful clinician investigators. Her mastery of cancer biology and genetics and their application to improving patients’ lives sets her apart. This type of interdisciplinary leadership combined with her consummate clinical skills, will provide remarkable direction as the division prepares for the new era of cancer care,” said Dr. Earp.
Dr. Carey is the principal investigator on multiple clinical trials conducted at UNC and across the nation. She co-leads the UNC Breast Cancer SPORE (Special Programs of Research Excellence) grant and is a nationally respected breast cancer expert who has been appointed to the National Cancer Institute (NCI) Committee that reviews and approves all of the NCI breast cancer trials. UNC Lineberger currently offers more than 225 clinical trials of the latest treatments developed at UNC or available through affiliation with national clinical trials groups.
Dr. Carey earned her undergraduate degree in Biology and Art History from Wellesley College. She completed her medical degree at Johns Hopkins University, was a resident on the Hopkins Osler service in Internal Medicine, then a fellow in Medical Oncology. She earned an advanced degree in Clinical Investigations at the Johns Hopkins School of Public Health in 1998.